Share this post on:

Product Name :
ARX-002

Search keywords :
JMJD6

drugId :
null

Target Vo:
Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6

Target Vo Short Name :
JMJD6

Moa_Name:
Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Rubicon Biotechnology Llc

Active Company_Name :
Rubicon Biotechnology Llc

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD8 alpha Antibody
AKT1 Antibody (YA634)
Ki67 Antibody (YA322): Ki67 Antibody (YA322) is a non-conjugated and Rabbit origined monoclonal antibody about 345-395 kDa, targeting to Ki67. It can be used for IHC,IF assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Betaine hydrochloride